Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
Date:8/9/2012

SAN DIEGO, Aug. 9, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the second quarter ended June 30, 2012, and reviewed recent developments.

At June 30, 2012, cash and cash equivalents totaled $143.8 million, which does not include (i) the $20.0 million milestone payment received from Eisai Inc. subsequent to June 30 for the inclusion of the efficacy and safety data from the Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) clinical trial in patients with type 2 diabetes in the US Food and Drug Administration (FDA)-approved prescribing information for BELVIQ (lorcaserin hydrochloride); (ii) $23.4 million received subsequent to June 30 from the exercise of warrants and stock options; or (iii) $65.0 million for milestone payments that Arena is eligible to receive from Eisai following US Drug Enforcement Administration (DEA) scheduling designation and delivery of BELVIQ launch supply to Eisai.

"The FDA's approval of BELVIQ in the second quarter was a significant development for obese and overweight Americans who need help losing weight," said Jack Lief, Arena's President and Chief Executive Officer. "We are focused on working with Eisai to launch BELVIQ in the United States following the completion of DEA scheduling, and expect BELVIQ to play a key role in physicians' newly expanded toolkits for the medical management of obesity. We also have marketing authorization applications under review in the European Union and Switzerland, and are in the process of prioritizing our commercial and regulatory strategy for additional markets outside of the United States."

Recent BELVIQ (lorcaserin HCl) Developments

  • Obtained FDA approval of BELVIQ as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management i
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
    2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
    3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
    4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
    5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
    6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
    7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
    8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
    9. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
    10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
    11. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2014)... MEETING, Pa. , Dec. 15, 2014 /PRNewswire/ ... announced today it has been added to the ... NASDAQ Biotechnology Index will become effective upon market ... NASDAQ Biotechnology Index is designed to track the ... are classified as either biotechnology or pharmaceutical according ...
    (Date:12/15/2014)... -- Colorado and Washington State are not ... Oregon , Alaska , ... the November 2014 elections. Photo - ... The benefits of legalizing cannabis are manifold. There ... increased tax revenue for state and local governments, in addition ...
    (Date:12/15/2014)... , Dec. 15, 2014 As medical ... (Structured Product Labeling) markup language standard, content teams have ... and skills to work with the standard. Starting January ... of three webinars on the benefits and the critical ... webinars will be facilitated by Howard Shatz , ...
    Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3
    ... YORK, April 6, 2011 KellBenx, a biotechnology ... diagnosis (NIPD) of genetic and inherited disorders, announced ... with AdnaGen, a wholly-owned subsidiary of Alere, Inc., ... will have exclusive worldwide rights to commercialize the ...
    ... 6, 2011 /PRNewswire/ -- Royal Philips ... United States availability of the Ingenia MRI system, ... solution. Previously available in Europe, Canada and Japan, ... U.S. Food and Drug Administration. Driven by Philips ...
    Cached Medicine Technology:KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies 2Philips to Take Orders for the Ingenia MRI System in the United States 2Philips to Take Orders for the Ingenia MRI System in the United States 3
    (Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... health, but a growing body of evidence shows the ancient ... In fact, the benefits were similar to those of ... Chu, a doctoral candidate at Harvard University,s Health Policy Program ... that people randomly assigned to take yoga classes saw improvements ...
    (Date:12/15/2014)... 15, 2014 Cancer researchers have just ... genetic causes of deadly malignant pleural mesothelioma. Surviving Mesothelioma ... their website. Click here to read it now. ... Hawaii Cancer Center, and New York’s Langone Medical Center ... mesothelioma patients in an effort to pinpoint the ...
    (Date:12/15/2014)... Beach, FL (PRWEB) December 15, 2014 South ... , knows that holidays can be a daze of hassle, ... slips and falls while decking halls, to burns when making ... of holiday hazards that can happen at any time. To ... pain, MD Now has made a list of helpful and ...
    (Date:12/15/2014)... MA (PRWEB) December 15, 2014 ... management solutions, announced today that it has received ... Quality Assurance (NCQA) for its Disease Management (DM) ... pulmonary disease (COPD), coronary heart disease and diabetes. ... from NCQA for Health Dialog’s Disease Management (DM) ...
    (Date:12/15/2014)... (PRWEB) December 15, 2014 The increase in ... one of the main factors which is contributing to the ... for the diagnosis and treatment of hearing loss and balance ... of three parts - microphone, speaker and amplifier. The global ... rate of 6.01% during the period from 2014 to 2019. ...
    Breaking Medicine News(10 mins):Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4
    ... By Steven Reinberg HealthDay Reporter , TUESDAY, June ... progression of type 1 diabetes shows some promise, while another ... of two new studies. The results of both studies ... Association annual meeting in San Diego. Type 1 diabetes ...
    ... Scientists from The Scripps Research Institute have identified a ... involved in wound-healing and sensory communication. The new ... 28, 2011, shows that in this process skin cells ... temperature-sensing and wound-healing. This alternative, oxygen-independent mode of nitric ...
    ... 28, 2011 Earl L. Smith III, O.D., dean of ... recently received an award for his work in slowing the ... holds the endowed Greeman-Petty Professor chair, accepted the Donald Korb ... contact lens and cornea section of the American Optometric Association ...
    ... (HealthDay News) -- Many members of low-income families are not ... In assessing the families, eating patterns and the nutritional ... 70 percent of the 100 families, who were newly enrolled ... amounts of several vital nutrients, including vitamins A and C, ...
    ... same cells that make insulin in the pancreas prevented and ... Michael,s Hospital have found. Type 1 diabetes, formerly known ... of the beta cells in the pancreas that make and ... no insulin. The only conventional treatment for Type ...
    ... come up with new insight into the brain processes that ... on the "X" in the center of the image in ... (Rocky, the mascot of the University of Rochester) appears to ... We simply think he is growing because our brains have ...
    Cached Medicine News:Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 3Health News:Scientists discover new molecular pathway involved in wound-healing and temperature sensation 2Health News:Scientists discover new molecular pathway involved in wound-healing and temperature sensation 3Health News:Work to slow progression of nearsightedness in children wins award 2Health News:Low-Income Families Often Miss Out on Proper Nutrition 2Health News:Chemical produced in pancreas prevented and reversed diabetes in mice 2Health News:Neuroscientists find famous optical illusion surprisingly potent 2
    The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
    Molt 9, excellent for subperiosteal tunneling....
    Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm)....
    Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
    Medicine Products: